Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgM|
|Immunogen||U937 histiocytic cell line.|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Immunohistochemistry (Frozen) (IHC (F))||Assay Dependent|
|Immunohistochemistry (Paraffin) (IHC (P))||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA1-26893 detects FUT4 from human samples.
MA1-26893 has been successfully used in immunohistochemistry (paraffin) procedures.
The MA1-26893 immunogen is U937 histiocytic cell line.
FUT4 may catalyze alpha-1,3 glycosidic linkages involved in the expression of Lewis X/SSEA-1 and VIM-2 antigens.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.
MA1-26893 was used in immunohistochemistry to study factors associated with nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome
|Lorenzi L,Tabellini G,Vermi W,Moratto D,Porta F,Notarangelo LD,Patrizi O,Sozzani S,de Saint Basile G,Latour S,Pace D,Lonardi S,Facchetti F,Badolato R,Parolini S||PloS one (8:null)||2013|
Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders.
MA1-26893 was used in immunohistochemistry to study three clinical cases of follicular dendritic cell sarcoma
|Lorenzi L,Lonardi S,Petrilli G,Tanda F,Bella M,Laurino L,Rossi G,Facchetti F||Human pathology (43:209)||2012|
Metastasis to the breast from an adenocarcinoma of the lung with extensive micropapillary component: a case report and review of the literature.
MA1-26893 was used in immunohistochemistry to report on a case of metastasis to the breast from an adenocarcinoma of the lung
|Maounis N,Chorti M,Legaki S,Ellina E,Emmanouilidou A,Demonakou M,Tsiafaki X||Diagnostic pathology (5:null)||2011|
Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy.
MA1-26893 was used in immunohistochemistry to study the role of innate and adaptive immunity in epileptogenesis and spontaneous seizures
|Ravizza T,Gagliardi B,Noé F,Boer K,Aronica E,Vezzani A||Neurobiology of disease (29:142)||2008|
Clear cell adenocarcinoma of the tunica vaginalis of the testis with an adjacent uterus-like tissue.
MA1-26893 was used in immunohistochemistry to report on a case of paratesticular clear cell carcinoma of the tunica vaginalis of the testis
|Tulunay O,Gögüş C,Baltaci S,Bulut S||Pathology international (54:641)||2004|
Clonogenic CD15 immunoreactive radial glial cells from the developing human lateral ganglionic eminence.
MA1-26893 was used in immunocytochemistry to study the sub-population of CD15-positive radial glial cells in the developing human lateral ganglionic eminence
|Buttler D,Mai JK,Ashwell KW,Andressen C||Current pharmaceutical biotechnology (14:29)||2013|
Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
MA1-26893 was used in immunocytochemistry to study inflammatory processes in cerebral lesions associated with tuberous sclerosis complex
|Boer K,Jansen F,Nellist M,Redeker S,van den Ouweland AM,Spliet WG,van Nieuwenhuizen O,Troost D,Crino PB,Aronica E||Epilepsy research (78:7)||2008|
3)-fucosyltransferase 4; alpha (1,3) fucosyltransferase, myeloid-specific; Alpha-(1; CD15; ELAM ligand fucosyltransferase; ELAM-1 ligand fucosyltransferase; ELFT; FCT3A; Fuc-TIV; fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific); fucosyltransferase IV; FucT-IV; galactoside 3-L-fucosyltransferase; Lewis X; stage-specific embryonic antigen 1
CD15; ELFT; FCT3A; FUC-TIV; FUT4; FUTIV; LeX; SSEA-1